FK 778

Drug Profile

FK 778

Alternative Names: HMR 1715; MNA 715; X 920715

Latest Information Update: 05 Jul 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Developer Astellas Pharma
  • Class Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Autoimmune disorders; Liver transplant rejection; Multiple sclerosis; Renal transplant rejection; Transplant rejection

Most Recent Events

  • 30 Jun 2006 Discontinued - Preclinical for Autoimmune disorders in Germany (unspecified route)
  • 30 Jun 2006 Discontinued - Preclinical for Multiple sclerosis in Germany (unspecified route)
  • 30 Jun 2006 Discontinued - Phase-II for Liver transplant rejection in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top